These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19920893)

  • 1. Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.
    Welliver M; McDonough J; Kalynych N; Redfern R
    Drug Des Devel Ther; 2009 Feb; 2():49-59. PubMed ID: 19920893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sugammadex for Reversal of Neuromuscular Blockade: Uses and Limitations.
    Hawkins J; Khanna S; Argalious M
    Curr Pharm Des; 2019; 25(19):2140-2148. PubMed ID: 31272347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex: A revolutionary drug in neuromuscular pharmacology.
    Nag K; Singh DR; Shetti AN; Kumar H; Sivashanmugam T; Parthasarathy S
    Anesth Essays Res; 2013; 7(3):302-6. PubMed ID: 25885973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study.
    Fábián ÁI; Tassonyi E; Csernoch V; Fedor M; Sohajda T; Szente L; Fülesdi B
    BMC Anesthesiol; 2021 Aug; 21(1):206. PubMed ID: 34404345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex, the first selective relaxant binding agent for neuromuscular block reversal.
    Stair C; Fernandez-Bustamante A
    Drugs Today (Barc); 2012 Jun; 48(6):405-13. PubMed ID: 22745926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
    Ren WH; Jahr JS
    Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the management of neuromuscular block: focus on sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Neuropsychiatr Dis Treat; 2007; 3(5):539-44. PubMed ID: 19300584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing for the unexpected: special considerations and complications after sugammadex administration.
    Iwasaki H; Renew JR; Kunisawa T; Brull SJ
    BMC Anesthesiol; 2017 Oct; 17(1):140. PubMed ID: 29041919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concept behind sugammadex.
    Epemolu O; Bom A
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
    Donati F
    Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M
    Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drug sugammadex: a selective relaxant binding agent.
    Welliver M
    AANA J; 2006 Oct; 74(5):357-63. PubMed ID: 17048555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
    Schaller SJ; Lewald H
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex: a selective relaxant-binding agent providing rapid reversal.
    Rex C; Bergner UA; Pühringer FK
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):461-5. PubMed ID: 20489603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex: a review of its use in anaesthetic practice.
    Yang LP; Keam SJ
    Drugs; 2009; 69(7):919-42. PubMed ID: 19441874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacology of sugammadex.
    Bom A; Hope F; Rutherford S; Thomson K
    J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.